With a market cap of $356.2 billion, North Chicago, Illinois-based AbbVie Inc. (ABBV) operates in the pharmaceutical sector.

AbbVie (ABBV) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.Shares of this ...

which is why it's considered a Dividend King despite its seemingly short history. By spinning off, AbbVie has been able to ...

Option chain shows key data for AbbVie's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for AbbVie.

Neurocrine Biosciences, Inc.'s potential for growth in the biopharma sector is strong despite recent setbacks, making its stock promising. Click for my NBIX update.

had a $354.1 billion market cap, putting it in the 100th percentile of all stocks. AbbVie Inc.’s stock is up 29.4% in 2024, up 5.8% in the previous five trading days and up 39.93% in the past year.

(NYSE:ABBV) reported a robust third quarter for 2024, with sales exceeding expectations and significant growth in key product segments.... AbbVie Inc . (NYSE:ABBV) has reached a remarkable milestone, ...

AbbVie Inc. Stock News As of November 6, 2024, Gilead Sciences, Inc. had a $112.3 billion market capitalization, compared to the Biotechnology median of $151.8 million. Gilead Sciences, Inc.’s stock ...

This month, we explore the 125-year-old history of ... company – AbbVie. In January 2013, AbbVie was formed. It began trading independently on the New York Stock Exchange on the 2nd January ...